Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
2.630
-0.430 (-14.05%)
At close: Dec 20, 2024, 4:00 PM
2.750
+0.120 (4.56%)
After-hours: Dec 20, 2024, 6:41 PM EST
Nexalin Technology Market Cap
Nexalin Technology has a market cap or net worth of $33.83 million as of December 20, 2024. Its market cap has increased by 1,036.87% in one year.
Market Cap
33.83M
Enterprise Value
29.23M
1-Year Change
1,036.87%
Ranking
Category
Stock Price
$2.63
Market Cap Chart
Since the IPO on September 16, 2022, Nexalin Technology's market cap has increased from $16.38M to $33.83M, an increase of 106.51%. That is a compound annual growth rate of 37.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 33.83M | 1,023.67% |
| Dec 29, 2023 | 3.01M | -44.79% |
| Dec 30, 2022 | 5.45M | -66.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 40.48M |
| Passage Bio | 40.40M |
| Achilles Therapeutics | 40.28M |
| Estrella Immunopharma | 39.80M |
| Daxor | 39.40M |
| Neuronetics | 39.15M |
| Lexaria Bioscience | 38.57M |
| SCYNEXIS | 38.33M |